The hormonal and spermicide-based contraceptive market in Sri Lanka grew steadily from 2013 to 2015, with significant growth spikes observed in 2016 and 2017. After a dip in 2022, the market exhibited a minor recovery by 2023, standing at $19.749 million. Over the last two years, the year-on-year variations were -6.65% in 2022 and 2.57% in 2023. The CAGR over the last five years is 2.83%.
Future trends to watch for:
- Potential regulatory changes impacting market growth.
- Evolving consumer preferences towards non-hormonal contraceptives.
- Technological advancements in contraceptive products.
- Socio-economic factors influencing demand.
- Awareness and educational campaigns on contraceptive usage.
